For Managing Acute Severe Asthma in Children:Nebulized Magnesium Sulphate in Combination with Beta2 Agonist versus Beta2 Agonist Alone

Comparative Efficacy of Nebulized Magnesium Sulphate in Combination with Beta2 Agonist versus Beta2 Agonist Alone for Managing Acute Severe Asthma in Children: A Single-Blinded Randomized Clinical Trial - nil

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/11/076229

Enrollment

Registered

2024-11-04

Start date

Unknown

Completion date

Unknown

Last updated

2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J984- Other disorders of lung

Interventions

Intervention1: mgso4 beta 2 agonist versus beta 2 agonist alone: nebulization of mgso4 in combination with beta 2 agonist versus beta 2 agonist alone Control Intervention1: mgso4 beta 2 agonist vers

Eligibility

Inclusion criteria

Inclusion criteria: The study is Randomized controlled study involving two treatment group The study participants of children age group between 5-18 years of both sex were randomly allocated to two treatment groups by using a computer generated simple randomization technique.

Exclusion criteria

Exclusion criteria: less than 5 years

Design outcomes

Primary

Measure	Time frame
to measure length of hospital stay improvement in the asthma severity scoreTimepoint: 1 week	—

Secondary

Measure	Time frame
to include all vitals within normal limits before dischargeTimepoint: 1 week	—

Countries

India

Contacts

Public ContactDrSujatha sridharan

Professor Department of Pediatrics chettinad hospital&research institute

sridharansujatha@gmail.com9282176464

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026